Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Brandl

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Frontiers in Cardiovascular Medicine|October 11, 2021
Effects of the Btk-Inhibitors Remibrutinib (LOU064) and Rilzabrutinib (PRN1008) With Varying Btk Selectivity Over Tec on Platelet Aggregation and <i>in vitro</i> Bleeding TimeRundan Duan, Luise Goldmann, Richard Brandl, et al.
Circulation|July 30, 2003
Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaquesEnno Rother, Richard Brandl, Daniel L Baker, et al.
Blood|March 22, 2018
Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque-triggered thrombus formation in humansKristina Busygina, Janina Jamasbi, Till Seiler, et al.
Journal of Thrombosis and Thrombolysis|March 23, 2011
The role of PGE(2) in human atherosclerotic plaque on platelet EP(3) and EP(4) receptor activation and platelet function in whole bloodLisa J Schober, Anna L Khandoga, Suman Dwivedi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 27, 2007
Membrane-type serine protease-1/matriptase induces interleukin-6 and -8 in endothelial cells by activation of protease-activated receptor-2: potential implications in atherosclerosisIsabell Seitz, Sibylle Hess, Henk Schulz, et al.
Journal of the American College of Cardiology|March 13, 2010
A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaquesArmin J Reininger, Isabell Bernlochner, Sandra M Penz, et al.
Human Molecular Genetics|December 25, 2002
A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasiaRainer Wessely, Ludger Hengst, Birgit Jaschke, et al.
Cardiovascular Research|March 3, 2022
Properties and fate of human mesenchymal stem cells upon miRNA let-7f-promoted recruitment to atherosclerotic plaquesVirginia Egea, Remco Theodorus Adrianus Megens, Donato Santovito, et al.
Thrombosis and Haemostasis|June 2, 2017
Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formationAnn-Katrin Mojica Muñoz, Janina Jamasbi, Kerstin Uhland, et al.
Thrombosis and Haemostasis|January 30, 2018
Dimeric Glycoprotein VI Binds to Collagen but Not to FibrinMariam Ebrahim, Janina Jamasbi, Kristin Adler, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Frontiers in Cardiovascular Medicine|October 11, 2021
Effects of the Btk-Inhibitors Remibrutinib (LOU064) and Rilzabrutinib (PRN1008) With Varying Btk Selectivity Over Tec on Platelet Aggregation and <i>in vitro</i> Bleeding TimeRundan Duan, Luise Goldmann, Richard Brandl, et al.
Circulation|July 30, 2003
Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaquesEnno Rother, Richard Brandl, Daniel L Baker, et al.
Blood|March 22, 2018
Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque-triggered thrombus formation in humansKristina Busygina, Janina Jamasbi, Till Seiler, et al.
Journal of Thrombosis and Thrombolysis|March 23, 2011
The role of PGE(2) in human atherosclerotic plaque on platelet EP(3) and EP(4) receptor activation and platelet function in whole bloodLisa J Schober, Anna L Khandoga, Suman Dwivedi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 27, 2007
Membrane-type serine protease-1/matriptase induces interleukin-6 and -8 in endothelial cells by activation of protease-activated receptor-2: potential implications in atherosclerosisIsabell Seitz, Sibylle Hess, Henk Schulz, et al.
Journal of the American College of Cardiology|March 13, 2010
A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaquesArmin J Reininger, Isabell Bernlochner, Sandra M Penz, et al.
Human Molecular Genetics|December 25, 2002
A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasiaRainer Wessely, Ludger Hengst, Birgit Jaschke, et al.
Cardiovascular Research|March 3, 2022
Properties and fate of human mesenchymal stem cells upon miRNA let-7f-promoted recruitment to atherosclerotic plaquesVirginia Egea, Remco Theodorus Adrianus Megens, Donato Santovito, et al.
Thrombosis and Haemostasis|June 2, 2017
Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formationAnn-Katrin Mojica Muñoz, Janina Jamasbi, Kerstin Uhland, et al.
Thrombosis and Haemostasis|January 30, 2018
Dimeric Glycoprotein VI Binds to Collagen but Not to FibrinMariam Ebrahim, Janina Jamasbi, Kristin Adler, et al.
Pageof 3